Suppr超能文献

谷胱甘肽S-转移酶P1(GSTP1)基因多态性与抗结核药物性肝毒性的发生率

Genetic Polymorphisms of Glutathione S-Transferase P1 (GSTP1) and the Incidence of Anti-Tuberculosis Drug-Induced Hepatotoxicity.

作者信息

Wu Shouquan, Wang You-Juan, Tang Xiaoyan, Wang Yu, Wu Jingcan, Ji Guiyi, Zhang Miaomiao, Chen Guo, Liu Qianqian, Sandford Andrew J, He Jian-Qing

机构信息

Department of Respiratory and Critical Care Medicine, West China Hospital, Sichuan University, Chengdu, Sichuan, China.

Physical Examination Center, West China Hospital, Sichuan University, Chengdu, Sichuan, China.

出版信息

PLoS One. 2016 Jun 9;11(6):e0157478. doi: 10.1371/journal.pone.0157478. eCollection 2016.

Abstract

BACKGROUND

Anti-tuberculosis drug-induced hepatotoxicity (ATDH) is one of the most common adverse effects associated with tuberculosis (TB) therapy. Animal studies have demonstrated important roles of glutathione S-transferases in the prevention of chemical-induced hepatotoxicity. The aim of this study was to investigate the relationship between single nucleotide polymorphisms (SNPs) of glutathione S-transferase P1 (GSTP1) and ATDH in TB patients.

METHODS

We used two independent samples for this genetic association study. In the initial prospective study, 322 newly diagnosed TB patients were followed up for three months after initiating anti-TB therapy. In an independent retrospective study, 115 ATDH patients and 116 patients without ATDH were selected to verify the results of the prospective study. Tag-SNPs of GSTP1 were genotyped either with the MassARRAY platform or the improved multiple ligase detection reaction (iMLDR) method. The associations between SNPs and ATDH were analyzed by logistic regression analysis adjusting for confounding factors.

RESULTS

Of the 322 patients recruited in the prospective cohort, 35 were excluded during the 3 months of follow-up, and 30 were diagnosed with ATDH and were considered as the ATDH group. The remaining 257 subjects without ATDH were considered as the non-ATDH group. After correction for potential confounding factors, significant differences were found for rs1695 (A>G) under an allelic model (OR = 3.876, 95%CI: 1.258011.905; P = 0.018). In the retrospective study, rs1695 allele A also had a higher risk of ATDH (OR = 2.10, 95%CI: 1.17-3.76; P = 0.012). We only found rs4147581AA genotype under a dominant model was related to ATDH in the prospective study (OR = 2.578, 95%CI: 1.076-6.173; P = 0.034).

CONCLUSIONS

This is the first study to suggest that GSTP1 genotyping can be an important tool for identifying patients who are susceptible to ATDH. This result should be verified in independent large sample studies and also in other ethnic populations.

摘要

背景

抗结核药物性肝毒性(ATDH)是与结核病(TB)治疗相关的最常见不良反应之一。动物研究已证明谷胱甘肽S-转移酶在预防化学诱导的肝毒性中起重要作用。本研究的目的是调查结核病患者中谷胱甘肽S-转移酶P1(GSTP1)的单核苷酸多态性(SNP)与ATDH之间的关系。

方法

我们使用两个独立样本进行这项基因关联研究。在最初的前瞻性研究中,322例新诊断的结核病患者在开始抗结核治疗后随访3个月。在一项独立的回顾性研究中,选择115例ATDH患者和116例无ATDH的患者以验证前瞻性研究的结果。使用MassARRAY平台或改进的多重连接检测反应(iMLDR)方法对GSTP1的标签SNP进行基因分型。通过调整混杂因素的逻辑回归分析来分析SNP与ATDH之间的关联。

结果

在前瞻性队列中招募的322例患者中,35例在3个月的随访期间被排除,30例被诊断为ATDH并被视为ATDH组。其余257例无ATDH的受试者被视为非ATDH组。在校正潜在的混杂因素后,在等位基因模型下发现rs1695(A>G)存在显著差异(OR = 3.876,95%CI:1.258 - 11.905;P = 0.018)。在回顾性研究中,rs1695等位基因A也具有较高的ATDH风险(OR = 2.10,95%CI:1.17 - 3.76;P = 0.012)。在前瞻性研究中,我们仅发现在显性模型下rs4147581AA基因型与ATDH相关(OR = 2.578,95%CI:1.076 - 6.173;P = 0.034)。

结论

这是第一项表明GSTP1基因分型可成为识别易患ATDH患者的重要工具的研究。这一结果应在独立的大样本研究以及其他种族人群中得到验证。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e7d/4900521/4a7c87c8eca2/pone.0157478.g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验